Results 71 to 80 of about 578 (168)

Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion

, 2017
Chronic spontaneous urticaria (CSU) is characterized by the sudden, continuous or intermittent appearance of pruritic wheals (hives), angioedema, or both for six weeks or more, with no known specific trigger.
Triggiani, Massimo, Ballmer-Weber, Barbara, Toubi, Elias, Knulst, André, Ballmer Weber, Barbara, Marsland, Alexander, Vestergaard, Christian, Maurer, Marcus, Ferrer, Marta, Ballmer-Weber, Barbara K., Giménez Arnau, Anna Maria, Giménez-Arnau, Ana, Giménez Arnau, Ana, Vestergaard C, Knulst A, Triggiani M, Marsland A, Infection & Immunity, MS Dermatologie/Allergologie, Toubi E, Ballmer-Weber B, Maurer M, Ferrer M, Giménez-Arnau A   +23 more
core   +1 more source

Perceived Acquired Resistance to Omalizumab in Obese Patients With Chronic Spontaneous Urticaria

Clinical &Experimental Allergy, Volume 56, Issue 6, Page 671-673, June 2026.
Francisco Martins, Ilaria Trave, Sofia Pereira, Margarida Gonçalo   +3 more
wiley   +1 more source

Effectiveness, Safety, and Tolerability of Bilastine Up-Dosing in Chronic Spontaneous Urticaria Uncontrolled with Licensed Doses of Other Second-Generation Antihistamines—An Institution-Based, Open-Label, Single-Group Longitudinal Trial

Indian Dermatology Online Journal
Background: Bilastine 20 mg daily is a second-generation antihistamine (sgAH) approved for chronic spontaneous urticaria (CSU). Up-dosing to 40 or 80 mg daily is recommended in uncontrolled patients.
Sankha S. Chakraborty, Indrashis Podder, Manisha Das, Arunima Dhabal   +3 more
doaj   +1 more source

Updosed Omalizumab in Chronic Spontaneous Urticaria With or Without Symptomatic Dermographism

Clinical and Experimental Dermatology
Abstract Background One-third of patients with chronic spontaneous urticaria (CSU) require treatment beyond the licensed dose of omalizumab, but real-world data on response and predictors of updosed omalizumab remain limited. Objectives
Muhammed Burak Yücel, Esranur Ünal, Mehmet Kılıç, Yılmaz Ulaş, Ragıp Ertaş, Clive E Grattan, Sinem Örnek Özdemir   +6 more
openaire   +1 more source

Management Principles in Urticaria

149152In the management of patients with urticaria some basic principles should be adhered to. Identification of underlying causes should have the first priority since the elimination or avoidance of triggers is the only causal way to treat the disease ...
Zuberbier, Torsten, Grattan, Ceh E.H., Maurer, Marcus   +2 more
core   +1 more source

Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial

, 2019
Objective: Long-term safety and efficacy of 10- and 20-mg rupatadine in Japanese patients with perennial allergic rhinitis (PAR) were investigated in a 52-week open-label study (JapicCTI-152952, clinicaltrials.jp).
Takamasa Suzuki (694834), Hiroshi Aoki (506655), Kimihiro Okubo (3124569), Ayaka Tanaka (6657977)   +3 more
core   +1 more source

Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY Project: Evaluation of A novel SLIT formulation during a Year).

, 2007
Compliance is a major determinant for allergy treatment, especially in children. Sublingual immunotherapy (SLIT) is self-managed at home, and no quantitative data on pediatric adherence are available.
LOMBARDI C, RIDOLO, Erminia, PECORA S, PASSALACQUA G, SACERDOTI G, SCHIVINO D, CADARIO G, SENNA G., AMOROSO S, ANTONICELLI L, DI GIOACCHINO M, MUSARRA A   +11 more
core   +1 more source

Exploratory study of tolerability and immunological effect of a short up-dosing immunotherapy phase with a standardised allergen extract derived from pollen of [PDF]

, 2015
Journal Article;BACKGROUND A new subcutaneous specific immunotherapy (SCIT) product adsorbed on aluminium hydroxide has been developed with a short and simplified up-dosing phase, containing a biologically standardized allergen pollen extract from Olea ...
Carmen Moreno, Carmen Panizo, Fernando Florido, Millan, Carmen, Carmen Millán, Saenz-De-San-Pedro, Blanca, Panizo, Carmen, Martin, Santiago, Blanca Sáenz De San Pedro, Florido, Fernando, Santiago Martín, Moreno, Carmen   +11 more
core   +1 more source

Clinical outcome and component-specific antibody levels in egg allergic children after lightened oral immunotherapy [PDF]

Objective: To evaluate the clinical outcome of lightened version of egg oral immunotherapy (OIT) and to analyze egg allergen component-specific antibody levels during short up-dosing with egg white powder and maintenance by egg in daily diet ...
Koffert Anna, Löyttyniemi Eliisa, Savolainen Johannes, Liippo Jussi   +3 more
core   +1 more source

Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing?

Journal of investigational allergology & clinical immunology, 2013
Nonsedating antihistamines are the first-choice treatment for all forms of urticaria. In patients with recalcitrant urticaria who do not respond to conventional doses of antihistamines, current guidelines recommend increasing doses by up to 4 times in order to obtain better control of the disease.
M, Sánchez-Borges, F, Caballero-Fonseca, A, Capriles-Hulett   +2 more
openaire   +1 more source